CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Mavena has created the Green Line, a series of medical devices for treating acne and nail fungal infections. Utilizing a novel concentrate of peracids, these devices effectively eliminate pathogens without antibiotics, improving treatment adherence and reducing the risk of microbial resistance.
Acne and onychomycosis (nail fungal infection) are two of the most common skin diseases, affecting up to 90% of teenagers and 10% of adults, respectively.
Acne is estimated to affect 9.4% of the global population, making it the eighth most prevalent disease worldwide.
In addition to the health and cosmetic damage, there are psycological consequences for these patients, which have a great negative impact in quality of life.
The current treatments for these diseases have limitations in terms of ef…
MAVENA INTERNATIONAL AG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
